Peter Eerligh

720 total citations
19 papers, 576 citations indexed

About

Peter Eerligh is a scholar working on Genetics, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Eerligh has authored 19 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 14 papers in Immunology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Eerligh's work include Diabetes and associated disorders (14 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (7 papers). Peter Eerligh is often cited by papers focused on Diabetes and associated disorders (14 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (7 papers). Peter Eerligh collaborates with scholars based in Netherlands, United Kingdom and Germany. Peter Eerligh's co-authors include Bart O. Roep, Bobby P. C. Koeleman, Alexandra Zhernakova, Cisca Wijmenga, Pilar Barrera, Arno R. van der Slik, G.J. Bruining, M. J. Giphart, T. Huizinga and Javier Martı́n and has published in prestigious journals such as Diabetes, Journal of General Virology and Human Genetics.

In The Last Decade

Peter Eerligh

19 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Eerligh Netherlands 12 290 285 129 106 105 19 576
Megan Tatum United States 8 424 1.5× 310 1.1× 141 1.1× 116 1.1× 92 0.9× 10 668
Alex Ilic United States 8 640 2.2× 345 1.2× 145 1.1× 86 0.8× 83 0.8× 10 940
Jörg Bertrams Germany 11 203 0.7× 219 0.8× 157 1.2× 115 1.1× 61 0.6× 16 470
Mickie Cheng United States 12 284 1.0× 195 0.7× 40 0.3× 125 1.2× 137 1.3× 20 618
Bergithe E Oftedal Norway 15 235 0.8× 262 0.9× 107 0.8× 457 4.3× 107 1.0× 44 748
Jae Lee United States 8 580 2.0× 530 1.9× 299 2.3× 181 1.7× 130 1.2× 8 1.1k
Laura Espino‐Paisán Spain 12 170 0.6× 144 0.5× 98 0.8× 39 0.4× 107 1.0× 29 454
Z Awdeh United States 8 448 1.5× 175 0.6× 100 0.8× 114 1.1× 110 1.0× 14 726
R Nissinen Finland 8 122 0.4× 165 0.6× 116 0.9× 27 0.3× 36 0.3× 25 359
John M. Barnard Canada 17 293 1.0× 347 1.2× 69 0.5× 239 2.3× 106 1.0× 24 729

Countries citing papers authored by Peter Eerligh

Since Specialization
Citations

This map shows the geographic impact of Peter Eerligh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Eerligh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Eerligh more than expected).

Fields of papers citing papers by Peter Eerligh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Eerligh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Eerligh. The network helps show where Peter Eerligh may publish in the future.

Co-authorship network of co-authors of Peter Eerligh

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Eerligh. A scholar is included among the top collaborators of Peter Eerligh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Eerligh. Peter Eerligh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Eerligh, Peter, Menno van Lummel, Arnaud Zaldumbide, et al.. (2011). Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. Genes and Immunity. 12(6). 415–427. 39 indexed citations
2.
Eerligh, Peter, Bobby P. C. Koeleman, Benedicte A. Lie, Bart O. Roep, & Erik Thorsby. (2011). No extreme genetic risk for type 1 diabetes among DR3/4‐DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband. Tissue Antigens. 77(4). 338–340. 1 indexed citations
3.
Persengiev, Stephan P., Bobby P. C. Koeleman, Kate Downes, et al.. (2010). Association analysis of myosin IXB and type 1 diabetes. Human Immunology. 71(6). 598–601. 10 indexed citations
4.
Slik, Arno R. van der, Peter Eerligh, Ilias I.N. Doxiadis, et al.. (2007). Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes. Tissue Antigens. 69(4). 348–353. 3 indexed citations
5.
Alizadeh, Behrooz Z., Peter Eerligh, Arno R. van der Slik, et al.. (2007). MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: An association and meta-analysis. Molecular Immunology. 44(11). 2806–2812. 20 indexed citations
6.
Zhernakova, Alexandra, B. Z. Alizadeh, Peter Eerligh, et al.. (2006). Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes and Immunity. 7(7). 544–549. 49 indexed citations
7.
Alizadeh, Behrooz Z., Peter Eerligh, Arno R. van der Slik, et al.. (2006). Su.38. Association of Interferon-γ and Interleukin 10 Genotypes and Serum Levels with Clinical Remission in Type 1 Diabetes. Clinical Immunology. 119. S172–S173. 3 indexed citations
8.
Alizadeh, B. Z., Pejman Hanifi-Moghaddam, Peter Eerligh, et al.. (2006). Association of interferon-γ and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes. Clinical & Experimental Immunology. 145(3). 480–484. 31 indexed citations
9.
Orozco, Gisela, Peter Eerligh, Elena Sánchez, et al.. (2005). Analysis of a Functional BTNL2 Polymorphism in Type 1 Diabetes, Rheumatoid Arthritis, and Systemic Lupus Erythematosus. Human Immunology. 66(12). 1235–1241. 58 indexed citations
10.
Zhernakova, Alexandra, Peter Eerligh, Cisca Wijmenga, et al.. (2005). Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes and Immunity. 6(6). 459–461. 90 indexed citations
11.
Zhernakova, Alexandra, Peter Eerligh, Pilar Barrera, et al.. (2005). CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Human Genetics. 118(1). 58–66. 58 indexed citations
12.
Bouwman, Lee H., Peter Eerligh, Onno T. Terpstra, et al.. (2005). Elevated Levels of Mannose-Binding Lectin at Clinical Manifestation of Type 1 Diabetes in Juveniles. Diabetes. 54(10). 3002–3006. 48 indexed citations
13.
Zhernakova, Alexandra, Peter Eerligh, Pilar Barrera, et al.. (2005). CTLA4 is differently associated with autoimmune diseases in the Dutch population. Human Genetics. 119(1-2). 225–225. 2 indexed citations
14.
Eerligh, Peter, Bobby P. C. Koeleman, Frank Dudbridge, et al.. (2004). Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes and Immunity. 5(1). 36–40. 35 indexed citations
15.
Eerligh, Peter, Bart O. Roep, M. J. Giphart, & Bobby P. C. Koeleman. (2004). Insulin‐like growth factor 1 promoter polymorphism influences insulin gene variable number of tandem repeat‐associated risk for juvenile onset type 1 diabetes. Tissue Antigens. 63(6). 568–571. 5 indexed citations
16.
Reusken, Chantal, Tim J. Dalebout, Peter Eerligh, Peter J. Bredenbeek, & Willy J. M. Spaan. (2003). Analysis of hepatitis C virus/classical swine fever virus chimeric 5′NTRs: sequences within the hepatitis C virus IRES are required for viral RNA replication. Journal of General Virology. 84(7). 1761–1769. 30 indexed citations
17.
Zanelli, Eric, Gavin C. Jones, M. Pascual, et al.. (2001). The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Human Immunology. 62(1). 75–84. 55 indexed citations
18.
Cheong, Karey, et al.. (2001). Localization of central MHC genes influencing type I diabetes. Human Immunology. 62(12). 1363–1370. 34 indexed citations
19.
Slik, Arno R. van der, Danielle C. Shing, Peter Eerligh, & Marius J. Giphart. (2000). Subtyping for TNFa microsatellite sequence variation. Immunogenetics. 52(1-2). 29–34. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Tatum Breakdown of academic impact, for papers by Alex Ilic Breakdown of academic impact, for papers by Jörg Bertrams Breakdown of academic impact, for papers by Mickie Cheng Breakdown of academic impact, for papers by Bergithe E Oftedal Breakdown of academic impact, for papers by Jae Lee Breakdown of academic impact, for papers by Laura Espino‐Paisán Breakdown of academic impact, for papers by Z Awdeh Breakdown of academic impact, for papers by R Nissinen Breakdown of academic impact, for papers by John M. Barnard
Rankless by CCL
2026